Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, August 8, 2019
[ Thu, Aug 08th 2019
] - WOPRAI
[ Thu, Aug 08th 2019
] - WOPRAI
[ Thu, Aug 08th 2019
] - WOPRAI
[ Thu, Aug 08th 2019
] - WOPRAI
[ Thu, Aug 08th 2019
] - WOPRAI
[ Thu, Aug 08th 2019
] - WOPRAI
Wed, August 7, 2019
[ Wed, Aug 07th 2019
] - WOPRAI
[ Wed, Aug 07th 2019
] - WOPRAI
[ Wed, Aug 07th 2019
] - WOPRAI
[ Wed, Aug 07th 2019
] - WOPRAI
[ Wed, Aug 07th 2019
] - WOPRAI
[ Wed, Aug 07th 2019
] - WOPRAI
[ Wed, Aug 07th 2019
] - WOPRAI
[ Wed, Aug 07th 2019
] - WOPRAI
[ Wed, Aug 07th 2019
] - WOPRAI
[ Wed, Aug 07th 2019
] - WOPRAI
[ Wed, Aug 07th 2019
] - WOPRAI
[ Wed, Aug 07th 2019
] - WOPRAI
[ Wed, Aug 07th 2019
] - WOPRAI
[ Wed, Aug 07th 2019
] - WOPRAI
Tue, August 6, 2019
[ Tue, Aug 06th 2019
] - WOPRAI
Gary Nachman Maintained (AMRX) at Hold with Decreased Target to $5 on, Aug 6th, 2019
Gary Nachman of BMO Capital, Maintained "Amneal Pharmaceuticals, Inc." (AMRX) at Hold with Decreased Target from $6 to $5 on, Aug 6th, 2019.
Gary has made no other calls on AMRX in the last 4 months.
There is 1 other peer that has a rating on AMRX. Out of the 1 peers that are also analyzing AMRX, all agrees with Gary's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Randall Stanicky of "RBC Capital" Downgraded from Buy to Hold and Decreased Target to $6 on, Thursday, July 11th, 2019
